PI3K
PI3K inhibitors are compounds that block the activity of Phosphoinositide 3-Kinases (PI3Ks), a family of enzymes involved in a wide range of cellular processes, including growth, proliferation, survival, and metabolism. The PI3K/Akt/mTOR pathway is often dysregulated in cancer, making PI3K a key target for cancer therapy. PI3K inhibitors are critical tools for studying signal transduction, cancer biology, and the development of targeted therapies. At CymitQuimica, we provide a variety of PI3K inhibitors to support your research in cell signaling, oncology, and therapeutic development.
Read more
GNE-490
CAS:1033739-92-2
GNE-490 is an effective inhibitor of pan-PI3K with IC50s of 3.5 nM, 25 nM, 5.2 …
Formula:
C18H22N6O2S
Purity:
96.74%
Color and Shape:
Solid
Molecular weight:
386.47
Ref: TM-T22339
| 1mg | 82.00 € | ||
| 2mg | 111.00 € | ||
| 5mg | 182.00 € | ||
| 10mg | 310.00 € | ||
| 25mg | 490.00 € | ||
| 50mg | 676.00 € | ||
| 100mg | 897.00 € | ||
| 200mg | 1,235.00 € | ||
| 1mL*10mM (DMSO) | 197.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
NVP-QAV-572
CAS:957209-68-6
NVP-QAV-572 is a inhibitor of PI3K(IC50 of 10 nM).
Formula:
C17H19F2N7O3S2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
471.5
Ref: TM-T12275
| 5mg | 232.00 € | ||
| 25mg | 711.00 € | ||
| 50mg | 928.00 € | ||
| 100mg | 1,411.00 € | ||
| 1mL*10mM (DMSO) | 264.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
Ginsenoside Rk1
CAS:494753-69-4
Ginsenoside Rk1 is a component created by processing the ginseng plant at high temperatures.
Formula:
C42H70O12
Purity:
99.13%
Color and Shape:
Solid
Molecular weight:
767
Ref: TM-T4S1499
| 5mg | 91.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
UCL-TRO-1938
CAS:2919575-27-0
UCL-TRO-1938 is a subtype-selective PI3Kα allosteric activator with cardioprotective and neuroregenerative effects.
Formula:
C27H32N6O
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
456.58
Ref: TM-T78092
| 5mg | 116.00 € | ||
| 10mg | 179.00 € | ||
| 25mg | 376.00 € | ||
| 50mg | 602.00 € | ||
| 100mg | 963.00 € | ||
| 200mg | 1,330.00 € | ||
| 1mL*10mM (DMSO) | 120.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
MSC2360844
CAS:1305267-37-1
MSC2360844 is a potent, orally active and selective inhibitor of PI3Kδ(IC50 of 145 nM).
Formula:
C26H27FN4O5S
Purity:
100% - 99.32%
Color and Shape:
Solid
Molecular weight:
526.58
Ref: TM-T12115
| 1mg | 51.00 € | ||
| 5mg | 112.00 € | ||
| 10mg | 175.00 € | ||
| 25mg | 342.00 € | ||
| 50mg | 547.00 € | ||
| 100mg | 868.00 € | ||
| 200mg | 1,162.00 € | ||
| 1mL*10mM (DMSO) | 130.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
CAL-130 Racemate
CAS:474012-90-3
CAL-130 Racemate is the racemate of CAL-130. CAL-130 is a PI3Kδ and PI3Kγ inhibitor (IC50s: …
Formula:
C23H22N8O
Purity:
98%
Color and Shape:
Solid
Molecular weight:
426.47
Ref: TM-T10660L2
| 25mg | 1,683.00 € | ||
| 50mg | 2,219.00 € | ||
| 100mg | 2,891.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
Duvelisib (R enantiomer)
CAS:1261590-48-0
Duvelisib R enantiomer (IPI-145 R enantiomer) is an enantiomer of Duvelisib with lower activity. Duvelisib …
Formula:
C22H17ClN6O
Purity:
98%
Color and Shape:
Solid
Molecular weight:
416.86
Ref: TM-T11129
| 1mg | 40.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
PI3K/VEGFR2-IN-1
CAS:2851067-08-6
PI3K/VEGFR2-IN-1 is a potent dual inhibitor targeting both PI3K and VEGFR2 with IC50 values of …
Formula:
C17H14ClN3OS
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
343.83
Ref: TM-T72713
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 10 Feb 2025
PI3K/mTOR Inhibitor-1
CAS:1949802-49-6
PI3K/mTOR Inhibitor-1 is a potent, orally bioavailable dual inhibitor of PI3K/mTOR (PI3Kα/PI3Kβ/PI3Kδ/PI3Kγ/mTOR with IC50s of …
Formula:
C18H22FN5O3S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
407.46
Ref: TM-T12460
| 25mg | 1,961.00 € | ||
| 50mg | 2,590.00 € | ||
| 100mg | 3,447.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
PI3Kδ-IN-17
CAS:2768181-63-9
PI3Kδ-IN-17 (Compound S5) is a potent PI3K δ inhibitor, exhibiting an IC50 value of 2.82 …
Formula:
C23H24F3N7O2
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
487.48
Ref: TM-T81468
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 10 Feb 2025
PI3K/mTOR Inhibitor-14
CAS:2919684-77-6
PI3K/mTOR Inhibitor-14 (compound Y-2) serves as a dual inhibitor of PI3K and mTOR, exhibiting IC50 …
Formula:
C28H30N8O3S
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
558.66
Ref: TM-T81470
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 10 Feb 2025
PIK-inhibitors
CAS:371934-59-7
PIK-inhibitors (MDK34597) is a pan PI3K inhibitors, an analog of PI-103.
Formula:
C19H17N5O2
Purity:
96.98%
Color and Shape:
Solid
Molecular weight:
347.37
Ref: TM-T3190
| 1mg | 64.00 € | ||
| 5mg | 131.00 € | ||
| 10mg | 229.00 € | ||
| 25mg | 413.00 € | ||
| 50mg | 532.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
PI3Kδ-IN-1
CAS:1911564-39-0
PI3Kδ-IN-1 is an efficacious PI3Kδ inhibitor (IC50 of 1.7 nM).
Formula:
C22H20F3N7O2
Purity:
99.3%
Color and Shape:
Solid
Molecular weight:
471.44
Ref: TM-T12462
| 1mg | 63.00 € | ||
| 5mg | 143.00 € | ||
| 10mg | 221.00 € | ||
| 25mg | 369.00 € | ||
| 50mg | 527.00 € | ||
| 100mg | 713.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
mTOR inhibitor 9d
CAS:1144075-38-6
mTOR inhibitor 9d is a dual inhibitor of the protein kinases mTOR and PI3K with …
Formula:
C21H23N5O3S
Purity:
98.90%
Color and Shape:
Soild
Molecular weight:
425.5
Ref: TM-T67702
| 1mg | 326.00 € | ||
| 5mg | 772.00 € | ||
| 10mg | 1,050.00 € | ||
| 25mg | 1,476.00 € | ||
| 50mg | 1,839.00 € | ||
| 100mg | 2,336.00 € | ||
| 500mg | 4,551.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
CXJ-2
CAS:2919976-92-2
CXJ-2, a cyclic peptide, binds EDPs, inhibits PI3K/ERK, and reduces hepatic cell growth/migration, offering antifibrotic …
Formula:
C55H87N15O22
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
1310.37
Ref: TM-T74782
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 10 Feb 2025
PI3K/mTOR Inhibitor-12
CAS:2891692-83-2
PI3K/mTOR Inhibitor-12: oral, potent, selective; IC50: PI3Kα 0.06 nM, mTOR 3.12 nM; strong antitumor; less …
Formula:
C27H27F2N9O4S
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
611.62
Ref: TM-T72374
| 25mg | 1,549.00 € | ||
| 50mg | 2,038.00 € | ||
| 100mg | 2,617.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
SAR-260301
CAS:1260612-13-2
SAR-260301 is an orally available and selective inhibitor of PI3Kβ (IC50: 23 nM).
Formula:
C19H22N4O3
Purity:
98.65%
Color and Shape:
Solid
Molecular weight:
354.4
Ref: TM-T16841
| 2mg | 44.00 € | ||
| 5mg | 67.00 € | ||
| 10mg | 89.00 € | ||
| 25mg | 177.00 € | ||
| 50mg | 269.00 € | ||
| 100mg | 378.00 € | ||
| 200mg | 533.00 € | ||
| 1mL*10mM (DMSO) | 72.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
PI3Kδ-IN-13
CAS:1686137-02-9
PI3Kδ-IN-13 (compound 89), with an IC50 value of 2.6 nM, is an inhibitor of PI3Kδ, …
Formula:
C27H39N7O4S2
Color and Shape:
Solid
Molecular weight:
589.77
Ref: TM-T79627
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 10 Feb 2025
LAS191954
CAS:1403947-26-1
LAS191954 is a selective, potent and orally active PI3Kδ inhibitor for inflammatory diseases treatment(IC50 : …
Formula:
C20H15N9O
Purity:
98%
Color and Shape:
Solid
Molecular weight:
397.39
Ref: TM-T11818
| 25mg | 1,827.00 € | ||
| 50mg | 2,404.00 € | ||
| 100mg | 3,168.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
GSK-F1
CAS:1402345-92-9
GSK-F1 (PI4KA inhibitor-F1) is a novel potent PI4KA inhibitor.
Formula:
C27H18F5N5O4S
Purity:
95.5%
Color and Shape:
Solid
Molecular weight:
603.52
Ref: TM-T19840
| 1mg | 106.00 € | ||
| 5mg | 218.00 € | ||
| 10mg | 323.00 € | ||
| 25mg | 519.00 € | ||
| 50mg | 703.00 € | ||
| 100mg | 903.00 € | ||
| 200mg | 1,272.00 € | ||
| 1mL*10mM (DMSO) | 309.00 € |
Estimated delivery in United States, on Monday 24 Feb 2025
